|
RICTOR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.845000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.562600E-04 |
| Normal-vs-Stage2 |
4.221000E-01 |
| Normal-vs-Stage3 |
3.142000E-02 |
| Normal-vs-Stage4 |
1.675800E-02 |
| Stage1-vs-Stage2 |
2.568600E-01 |
| Stage1-vs-Stage3 |
9.524600E-01 |
| Stage1-vs-Stage4 |
6.470600E-01 |
| Stage2-vs-Stage3 |
3.701400E-01 |
| Stage2-vs-Stage4 |
3.093600E-01 |
| Stage3-vs-Stage4 |
7.218600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.862000E-03 |
| Normal-vs-AfricanAmerican |
2.373800E-02 |
| Normal-vs-Asian |
7.395200E-03 |
| Caucasian-vs-AfricanAmerican |
9.935000E-01 |
| Caucasian-vs-Asian |
3.783200E-01 |
| AfricanAmerican-vs-Asian |
4.170600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.615500E-04 |
| Normal-vs-Female |
6.286200E-01 |
| Male-vs-Female |
1.381510E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.907800E-02 |
| Normal-vs-Extreme_Weight |
7.227100E-04 |
| Normal-vs-Obese |
1.449650E-02 |
| Normal-vs-Extreme_Obese |
1.795680E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.836800E-01 |
| Normal_Weight-vs-Obese |
9.214200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.183200E-01 |
| Extreme_Weight-vs-Obese |
3.576400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.824200E-01 |
| Obese-vs-Extreme_Obese |
5.949600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.676800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.585370E-01 |
| Normal-vs-Age(61-80Yrs) |
6.35580000000191E-05 |
| Normal-vs-Age(81-100Yrs) |
1.737540E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.488800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.887800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.073200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.318200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.609200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.910800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.038200E-03 |
| Normal-VS-Type2 PRCC |
6.047100E-04 |
| Normal-VS-KIRP CIMP |
1.612150E-02 |
| Normal-VS-Unclassified PRCC |
7.501400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.664770E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.317000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.935780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.902000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.451500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.237850E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.951380E-04 |
| Normal-vs-N1 |
2.051000E-01 |
| Normal-vs-N2 |
1.048360E-02 |
| N0-vs-N1 |
1.270440E-01 |
| N0-vs-N2 |
6.046800E-01 |
| N1-vs-N2 |
3.140000E-01 |
|
|
